Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Equity Ratio (2019 - 2025)

Biodesix's Equity Ratio history spans 7 years, with the latest figure at 0.03 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 113.13% year-over-year to 0.03; the TTM value through Dec 2025 reached 0.03, down 113.13%, while the annual FY2025 figure was 0.03, 113.13% down from the prior year.
  • Equity Ratio reached 0.03 in Q4 2025 per BDSX's latest filing, down from 0.02 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.32 in Q1 2021 to a low of 0.09 in Q2 2023.
  • Average Equity Ratio over 5 years is 0.11, with a median of 0.11 recorded in 2022.
  • The largest YoY upside for Equity Ratio was 1727.28% in 2024 against a maximum downside of 212.04% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.26 in 2021, then dropped by 14.44% to 0.22 in 2022, then tumbled by 79.16% to 0.05 in 2023, then skyrocketed by 364.49% to 0.21 in 2024, then crashed by 113.13% to 0.03 in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Equity Ratio are 0.03 (Q4 2025), 0.02 (Q3 2025), and 0.01 (Q2 2025).